| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,718 |
16,988 |
$955K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,437 |
5,367 |
$453K |
| 99051 |
|
14,248 |
13,506 |
$316K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,916 |
5,575 |
$195K |
| 87428 |
|
5,997 |
5,802 |
$157K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,083 |
3,039 |
$154K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,115 |
2,983 |
$107K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,541 |
1,514 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
1,709 |
1,652 |
$37K |
| 87634 |
|
338 |
335 |
$23K |
| 99215 |
Prolong outpt/office vis |
301 |
293 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,524 |
1,331 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,845 |
2,772 |
$19K |
| 87070 |
|
2,679 |
2,503 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
505 |
489 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
874 |
846 |
$10K |
| 87088 |
|
1,207 |
1,135 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
361 |
356 |
$8K |
| 81002 |
|
2,399 |
2,277 |
$8K |
| 73630 |
|
393 |
374 |
$7K |
| 73610 |
|
256 |
247 |
$7K |
| 99173 |
|
892 |
860 |
$5K |
| 93000 |
|
247 |
237 |
$4K |
| 73130 |
|
102 |
97 |
$2K |
| 72100 |
|
49 |
49 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
65 |
64 |
$1K |
| 99205 |
Prolong outpt/office vis |
16 |
15 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
62 |
62 |
$1K |
| 86308 |
|
116 |
112 |
$804.29 |
| 73110 |
|
27 |
27 |
$477.74 |
| 86618 |
|
13 |
12 |
$466.02 |
| 81025 |
|
110 |
106 |
$448.80 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$343.20 |
| 73030 |
|
12 |
12 |
$287.98 |
| 73600 |
|
13 |
13 |
$227.70 |
| 99000 |
|
68 |
59 |
$217.00 |
| 82962 |
|
12 |
12 |
$19.80 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
14 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
12 |
12 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$0.00 |